Nevra Alkanli

17PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 27, 2026
Impact of MMP1, MMP2, and MMP3 Gene Variations on Susceptibility to Peyronie's Disease and Clinical Progression.

|Jul 15, 2026
Genetic Susceptibility to Diabetic Retinopathy in the Thrace Region: Role of IL-18 (-607 C/A, -137 G/C) and IL-8 (-251 A/T) Variations.

|Jun 26, 2026
Inflammatory Cytokine Genetics and Coronary Artery Disease: Pathogenetic and Protective Analysis of IL-18 (-607 C/A, -137 G/C) and IL-8 (+781 C/T) Gene Variations.

|May 13, 2026
Differential Roles of IL-18 and IL-8 Gene Variations in Multiple Sclerosis: Associations with Susceptibility and MRI Disease Activity.

|Jan 30, 2026
Investigation of the Correlation Between Selected miRNAs, Proinflammatory Cytokines, and Serum Trace Elements in Bladder Cancer Development and Progression.

Arzu Ay, Nevra Alkanli, Engin Atli

|Oct 28, 2025
Genotype Combinations and Genetic Risk Score Analyses of MTHFR, MTRR, and MTR Polymorphisms in Hypothyroidism Susceptibility: A Case-Control Study.

Nilgun Tan Tabakoglu, Arzu Ay, Nevra Alkanli

Pageof 3

Frequent Collaborators

16 joint publications

Arzu Ay

7 joint publications

Gokhan Cevik

4 joint publications

Necdet Sut

3 joint publications

Tammam Sipahi